CIMR: In vivo Context

Sponsor: Metabolomics Society http://www.metabolomicssociety.org/ Reference: http://msi-workgroups.sourceforge.net/bio-metadata/reporting/invivo/ Version: 1.8 Date: 2006/06/20 15:01:18 Authors: Clare Daykin, Nottingham, UK <clare.daykin@nottingham.ac.uk> Jules Griffin, Cambridge, UK <jlg40@mole.bio.cam.ac.uk> Sarah Heald, Bayer, USA <sarah.heald.b@bayer.com> Hector Keun, Imperial College London, UK <h.keun@imperial.ac.uk> Andrew Nicholls, GSK, UK <andrew.w.nicholls@gsk.com> Don Robertson, Pfzier, UK <Donald.Robertson@pfizer.com> Ina Shuppe, Astra Zeneca, Sweden <ina.schuppe-koistinen@astrazeneca.com> John Griffiths, St. George's Hospital, London, UK <sgbc100@sghms.ac.uk> Leo Cheng, Harvard Medical School & MGH, Boston, USA <cheng@nmr.mgh.harvard.edu> Philippe Rocca-Serra, European Bioinformatics Institute <rocca@ebi.ac.uk> Edited by Nigel Hardy Credits: Chair: Jules Griffin

[1]  L. Poston,et al.  Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial , 2006, The Lancet.

[2]  G. Pond,et al.  Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer , 2006, British Journal of Cancer.

[3]  A. Kong,et al.  Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. , 2006, Cancer research.

[4]  M. Piccart,et al.  Phase I Trial of Sorafenib and Gemcitabine in Advanced Solid Tumors with an Expanded Cohort in Advanced Pancreatic Cancer , 2006, Clinical Cancer Research.

[5]  M. Wade,et al.  Short-term oral toxicity of butyl ether, ethyl hexyl ether, methyl heptyl ether and 1,6-dimethoxyhexane in male rats and the role of 2-methoxyacetic acid. , 2005, Toxicology.

[6]  J. Minna,et al.  Imatinib Mesylate Efficiently Achieves Therapeutic Intratumor Concentrations in Vivo but Has Limited Activity in a Xenograft Model of Small Cell Lung Cancer , 2004, Clinical Cancer Research.

[7]  Jeremy K Nicholson,et al.  Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. , 2004, Chemical research in toxicology.

[8]  J. Nicholson,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.

[9]  Steve D. M. Brown,et al.  Novel phenotypes identified by plasma biochemical screening in the mouse , 2002, Mammalian Genome.

[10]  D. Sawyer,et al.  Mice Lacking Inducible Nitric Oxide Synthase Have Improved Left Ventricular Contractile Function and Reduced Apoptotic Cell Death Late After Myocardial Infarction , 2001, Circulation research.

[11]  L. Poston,et al.  Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial , 2006, The Lancet.